Literature DB >> 25480495

The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.

Niels Weinhold1, Tobias Meissner2, David C Johnson3, Anja Seckinger1, Jérôme Moreaux4, Asta Försti5, Bowang Chen6, Jolanta Nickel1, Daniel Chubb7, Andrew C Rawstron8, Chi Doughty8, Nasrin B Dahir3, Dil B Begum3, Kwee Young9, Brian A Walker3, Per Hoffmann10, Marcus M Nöthen11, Faith E Davies3, Bernard Klein4, Hartmut Goldschmidt12, Gareth J Morgan3, Richard S Houlston7, Dirk Hose13, Kari Hemminki5.   

Abstract

Entities:  

Keywords:  eQTL; multiple myeloma; risk; single nucleotide polymorphism

Mesh:

Substances:

Year:  2014        PMID: 25480495      PMCID: PMC4349291          DOI: 10.3324/haematol.2014.118786

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine.

Authors:  Tobias Meissner; Anja Seckinger; Thierry Rème; Thomas Hielscher; Thomas Möhler; Kai Neben; Hartmut Goldschmidt; Bernard Klein; Dirk Hose
Journal:  Clin Cancer Res       Date:  2011-10-10       Impact factor: 12.531

2.  Identification of a novel c-Myc protein interactor, JPO2, with transforming activity in medulloblastoma cells.

Authors:  Annie Huang; Cynthia S W Ho; Romina Ponzielli; Dalia Barsyte-Lovejoy; Eric Bouffet; Daniel Picard; Cynthia E Hawkins; Linda Z Penn
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 3.  Architecture of inherited susceptibility to common cancer.

Authors:  Olivia Fletcher; Richard S Houlston
Journal:  Nat Rev Cancer       Date:  2010-05       Impact factor: 60.716

4.  IRF4 addiction in multiple myeloma.

Authors:  Arthur L Shaffer; N C Tolga Emre; Laurence Lamy; Vu N Ngo; George Wright; Wenming Xiao; John Powell; Sandeep Dave; Xin Yu; Hong Zhao; Yuxin Zeng; Bangzheng Chen; Joshua Epstein; Louis M Staudt
Journal:  Nature       Date:  2008-06-22       Impact factor: 49.962

Review 5.  IRF4: Immunity. Malignancy! Therapy?

Authors:  Arthur L Shaffer; N C Tolga Emre; Paul B Romesser; Louis M Staudt
Journal:  Clin Cancer Res       Date:  2009-04-21       Impact factor: 12.531

6.  An in vitro model of differentiation of memory B cells into plasmablasts and plasma cells including detailed phenotypic and molecular characterization.

Authors:  Michel Jourdan; Anouk Caraux; John De Vos; Geneviève Fiol; Marion Larroque; Chantal Cognot; Caroline Bret; Christophe Duperray; Dirk Hose; Bernard Klein
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

7.  Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma.

Authors:  Brian A Walker; Paola E Leone; Matthew W Jenner; Cheng Li; David Gonzalez; David C Johnson; Fiona M Ross; Faith E Davies; Gareth J Morgan
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

8.  IRF4 is a suppressor of c-Myc induced B cell leukemia.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; James Eudy; Kay-Uwe Wagner; Shantaram S Joshi; Runqing Lu
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

9.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk.

Authors:  Daniel Chubb; Niels Weinhold; Peter Broderick; Bowang Chen; David C Johnson; Asta Försti; Jayaram Vijayakrishnan; Gabriele Migliorini; Sara E Dobbins; Amy Holroyd; Dirk Hose; Brian A Walker; Faith E Davies; Walter A Gregory; Graham H Jackson; Julie A Irving; Guy Pratt; Chris Fegan; James Al Fenton; Kai Neben; Per Hoffmann; Markus M Nöthen; Thomas W Mühleisen; Lewin Eisele; Fiona M Ross; Christian Straka; Hermann Einsele; Christian Langer; Elisabeth Dörner; James M Allan; Anna Jauch; Gareth J Morgan; Kari Hemminki; Richard S Houlston; Hartmut Goldschmidt
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

10.  Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk.

Authors:  Peter Broderick; Daniel Chubb; David C Johnson; Niels Weinhold; Asta Försti; Amy Lloyd; Bianca Olver; Yussanne Ma; Sara E Dobbins; Brian A Walker; Faith E Davies; Walter A Gregory; J Anthony Childs; Fiona M Ross; Graham H Jackson; Kai Neben; Anna Jauch; Per Hoffmann; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Ian P Tomlinson; Hartmut Goldschmidt; Kari Hemminki; Gareth J Morgan; Richard S Houlston
Journal:  Nat Genet       Date:  2011-11-27       Impact factor: 38.330

View more
  17 in total

1.  Polymorphisms in CARS are associated with gastric cancer risk: a two-stage case-control study in the Chinese population.

Authors:  Tian Tian; Ling Xiao; Jiangbo Du; Xun Zhu; Yayun Gu; Na Qin; Caiwang Yan; Li Liu; Hongxia Ma; Yue Jiang; Jiaping Chen; Hao Yu; Juncheng Dai
Journal:  Gastric Cancer       Date:  2017-04-13       Impact factor: 7.370

2.  A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.

Authors:  Kristin A Rand; Chi Song; Eric Dean; Daniel J Serie; Karen Curtin; Xin Sheng; Donglei Hu; Carol Ann Huff; Leon Bernal-Mizrachi; Michael H Tomasson; Sikander Ailawadhi; Seema Singhal; Karen Pawlish; Edward S Peters; Cathryn H Bock; Alex Stram; David J Van Den Berg; Christopher K Edlund; David V Conti; Todd Zimmerman; Amie E Hwang; Scott Huntsman; John Graff; Ajay Nooka; Yinfei Kong; Silvana L Pregja; Sonja I Berndt; William J Blot; John Carpten; Graham Casey; Lisa Chu; W Ryan Diver; Victoria L Stevens; Michael R Lieber; Phyllis J Goodman; Anselm J M Hennis; Ann W Hsing; Jayesh Mehta; Rick A Kittles; Suzanne Kolb; Eric A Klein; Cristina Leske; Adam B Murphy; Barbara Nemesure; Christine Neslund-Dudas; Sara S Strom; Ravi Vij; Benjamin A Rybicki; Janet L Stanford; Lisa B Signorello; John S Witte; Christine B Ambrosone; Parveen Bhatti; Esther M John; Leslie Bernstein; Wei Zheng; Andrew F Olshan; Jennifer J Hu; Regina G Ziegler; Sarah J Nyante; Elisa V Bandera; Brenda M Birmann; Sue A Ingles; Michael F Press; Djordje Atanackovic; Martha J Glenn; Lisa A Cannon-Albright; Brandt Jones; Guido Tricot; Thomas G Martin; Shaji K Kumar; Jeffrey L Wolf; Sandra L Deming Halverson; Nathaniel Rothman; Angela R Brooks-Wilson; S Vincent Rajkumar; Laurence N Kolonel; Stephen J Chanock; Susan L Slager; Richard K Severson; Nalini Janakiraman; Howard R Terebelo; Elizabeth E Brown; Anneclaire J De Roos; Ann F Mohrbacher; Graham A Colditz; Graham G Giles; John J Spinelli; Brian C Chiu; Nikhil C Munshi; Kenneth C Anderson; Joan Levy; Jeffrey A Zonder; Robert Z Orlowski; Sagar Lonial; Nicola J Camp; Celine M Vachon; Elad Ziv; Daniel O Stram; Dennis J Hazelett; Christopher A Haiman; Wendy Cozen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-09-01       Impact factor: 4.254

3.  A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Authors:  Zhaohui Du; Niels Weinhold; Gregory Chi Song; Kristin A Rand; David J Van Den Berg; Amie E Hwang; Xin Sheng; Victor Hom; Sikander Ailawadhi; Ajay K Nooka; Seema Singhal; Karen Pawlish; Edward S Peters; Cathryn Bock; Ann Mohrbacher; Alexander Stram; Sonja I Berndt; William J Blot; Graham Casey; Victoria L Stevens; Rick Kittles; Phyllis J Goodman; W Ryan Diver; Anselm Hennis; Barbara Nemesure; Eric A Klein; Benjamin A Rybicki; Janet L Stanford; John S Witte; Lisa Signorello; Esther M John; Leslie Bernstein; Antoinette M Stroup; Owen W Stephens; Maurizio Zangari; Frits Van Rhee; Andrew Olshan; Wei Zheng; Jennifer J Hu; Regina Ziegler; Sarah J Nyante; Sue Ann Ingles; Michael F Press; John David Carpten; Stephen J Chanock; Jayesh Mehta; Graham A Colditz; Jeffrey Wolf; Thomas G Martin; Michael Tomasson; Mark A Fiala; Howard Terebelo; Nalini Janakiraman; Laurence Kolonel; Kenneth C Anderson; Loic Le Marchand; Daniel Auclair; Brian C-H Chiu; Elad Ziv; Daniel Stram; Ravi Vij; Leon Bernal-Mizrachi; Gareth J Morgan; Jeffrey A Zonder; Carol Ann Huff; Sagar Lonial; Robert Z Orlowski; David V Conti; Christopher A Haiman; Wendy Cozen
Journal:  Blood Adv       Date:  2020-01-14

Review 4.  Evolutionary biology of high-risk multiple myeloma.

Authors:  Charlotte Pawlyn; Gareth J Morgan
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

5.  Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.

Authors:  M I da Silva Filho; A Försti; N Weinhold; I Meziane; C Campo; S Huhn; J Nickel; P Hoffmann; M M Nöthen; K-H Jöckel; S Landi; J S Mitchell; D Johnson; G J Morgan; R Houlston; H Goldschmidt; A Jauch; P Milani; G Merlini; D Rowcieno; P Hawkins; U Hegenbart; G Palladini; A Wechalekar; S O Schönland; K Hemminki
Journal:  Leukemia       Date:  2016-12-27       Impact factor: 11.528

6.  Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma.

Authors:  Xiaomu Wei; M Nieves Calvo-Vidal; Siwei Chen; Gang Wu; Maria V Revuelta; Jian Sun; Jinghui Zhang; Michael F Walsh; Kim E Nichols; Vijai Joseph; Carrie Snyder; Celine M Vachon; James D McKay; Shu-Ping Wang; David S Jayabalan; Lauren M Jacobs; Dina Becirovic; Rosalie G Waller; Mykyta Artomov; Agnes Viale; Jayeshkumar Patel; Jude Phillip; Selina Chen-Kiang; Karen Curtin; Mohamed Salama; Djordje Atanackovic; Ruben Niesvizky; Ola Landgren; Susan L Slager; Lucy A Godley; Jane Churpek; Judy E Garber; Kenneth C Anderson; Mark J Daly; Robert G Roeder; Charles Dumontet; Henry T Lynch; Charles G Mullighan; Nicola J Camp; Kenneth Offit; Robert J Klein; Haiyuan Yu; Leandro Cerchietti; Steven M Lipkin
Journal:  Cancer Res       Date:  2018-03-20       Impact factor: 12.701

7.  Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6.

Authors:  Alyssa Clay-Gilmour; Subhayan Chattopadhyay; Celine M Vachon; Kari Hemminki; Michelle A T Hildebrandt; Hauke Thomsen; Niels Weinhold; Pavel Vodicka; Ludmila Vodickova; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Börge Schmidt; Christian Langer; Roman Hajek; Göran Hallmans; Ulrika Pettersson-Kymmer; Claes Ohlsson; Florentin Späth; Richard Houlston; Hartmut Goldschmidt; Elisabet E Manasanch; Aaron Norman; Shaji Kumar; S Vincent Rajkumar; Susan Slager; Asta Försti
Journal:  Blood Cancer J       Date:  2022-04-13       Impact factor: 11.037

8.  Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression.

Authors:  Ni Li; David C Johnson; Niels Weinhold; James B Studd; Giulia Orlando; Fabio Mirabella; Jonathan S Mitchell; Tobias Meissner; Martin Kaiser; Hartmut Goldschmidt; Kari Hemminki; Gareth J Morgan; Richard S Houlston
Journal:  Nat Commun       Date:  2016-11-24       Impact factor: 14.919

9.  Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.

Authors:  Philip J Law; Amit Sud; Jonathan S Mitchell; Marc Henrion; Giulia Orlando; Oleg Lenive; Peter Broderick; Helen E Speedy; David C Johnson; Martin Kaiser; Niels Weinhold; Rosie Cooke; Nicola J Sunter; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; David J Allsup; Jonathan Carmichael; James R Bailey; Guy Pratt; Thahira Rahman; Chris Pepper; Chris Fegan; Elke Pogge von Strandmann; Andreas Engert; Asta Försti; Bowang Chen; Miguel Inacio da Silva Filho; Hauke Thomsen; Per Hoffmann; Markus M Noethen; Lewin Eisele; Karl-Heinz Jöckel; James M Allan; Anthony J Swerdlow; Hartmut Goldschmidt; Daniel Catovsky; Gareth J Morgan; Kari Hemminki; Richard S Houlston
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

10.  Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.

Authors:  David C Johnson; Niels Weinhold; Jonathan S Mitchell; Bowang Chen; Martin Kaiser; Dil B Begum; Jens Hillengass; Uta Bertsch; Walter A Gregory; David Cairns; Graham H Jackson; Asta Försti; Jolanta Nickel; Per Hoffmann; Markus M Nöethen; Owen W Stephens; Bart Barlogie; Faith E Davis; Kari Hemminki; Hartmut Goldschmidt; Richard S Houlston; Gareth J Morgan
Journal:  Nat Commun       Date:  2016-01-08       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.